Detalles de la búsqueda
1.
Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer.
Int J Mol Sci
; 20(15)2019 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31387239
2.
Patterns of neurological adverse events among a retrospective cohort of patients receiving immune checkpoint inhibitors.
Immunotherapy
; 16(6): 381-390, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38197144
3.
Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer.
Ther Adv Med Oncol
; 16: 17588359231217959, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38249330
4.
Durable response to amivantamab in treatment refractory NSCLC harboring EGFR and complex MET mutations: A case report.
Lung Cancer
; 186: 107400, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37856922
5.
Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case report and review of the literature.
Ther Adv Med Oncol
; 15: 17588359231193722, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37667781
6.
A Case Report of Immune Checkpoint Inhibitor-Induced Aortitis Treated with Tocilizumab.
Case Reports Immunol
; 2022: 7971169, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36277471
7.
A Review of the Role of Oral Microbiome in the Development, Detection, and Management of Head and Neck Squamous Cell Cancers.
Cancers (Basel)
; 14(17)2022 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36077651
8.
Serendipitous synergism - an exceptional response to treatment with pembrolizumab in the course of a natural immunovirotherapy: a case report and review of the literature.
Ther Adv Med Oncol
; 14: 17588359221122729, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36312814
Resultados
1 -
8
de 8
1
Próxima >
>>